Ignite Creation Date:
2024-05-06 @ 3:13 PM
Last Modification Date:
2024-10-26 @ 1:45 PM
Study NCT ID:
NCT04565054
Status:
RECRUITING
Last Update Posted:
2024-03-01
First Post:
2020-07-07
Brief Title:
Adjuvant Therapy With Abemaciclib SOC ET vs SOC ET in Clinical or Genomic High Risk HRHER2- EBC
Sponsor:
West German Study Group
Organization:
West German Study Group
Organization Data
Organization:
West German Study Group
Class:
OTHER
Study ID:
WSG-AM11
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West German Study Group
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genomic Health Inc | INDUSTRY |
| Eli Lilly and Company | INDUSTRY |